Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Centessa Pharmaceuticals PLC ADR
CNTACurrent price
14.3 USD
-0.36 USD (-2.46%)
Last closed
14.6 USD
Company
www.centessa.com
ISIN
US1523091007
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 529 739 008 USD
Yield for 12 month
+121.36 %
1Y
3Y
5Y
10Y
15Y
CNTA
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipeline includes SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of narcolepsy and other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, a bi-specific monoclonal antibody for solid tumors, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; and OX2R Agonists compounds are currently in development for the treatment of narcolepsy. In addition, its products pipeline comprises ORX750, an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and earlier-stage preclinical assets and discovery-stage programs. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom. Address: 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
14.5 USDP/E ratio
–Dividend Yield
–Current Year
+6 879 562 USD
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
+6 066 423 USD
Last Year
-130 919 USD
Current Quarter
-236 264 USD
Last Quarter
-239 862 USD
Key Figures CNTA
1 year
3 years
5 years
10 years
EBITDA
-155 099 008 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.54 %
PEG Ratio
–
Return On Equity TTM
-55.84 %
Wall Street Target Price
14.5 USD
Revenue TTM
6 853 000 USD
Book Value
2.54 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.55 USD
Diluted Eps TTM
-1.55 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CNTA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CNTA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CNTA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
192.6978
Price Sales TTM
223.2218
Enterprise Value EBITDA
1.1183
Price Book MRQ
5.3308
Financials CNTA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CNTA
For 52 weeks
5.15 USD
14.48 USD
50 Day MA
10.62 USD
Shares Short Prior Month
1 384 705
200 Day MA
9.37 USD
Short Ratio
3.35
Shares Short
1 100 048
Short Percent
1.24 %
BeatStart